Optimizing Multiple Myeloma Care: Expert Guidance for the Practicing Clinician Online Goal Statement The goal of this activity is to improve the knowledge, competence, and performance of learners to integrate current and emerging therapies into the treatment of patients with multiple myeloma... Konferenz...
Treatment Options and Course of Action in Relapsed Multiple Myeloma Latest CME Events & Activities Community Practice Connections™: Pre-Conference Workshop on Immune Cell-Based Therapy View More Go To PER in Chicago May 30, 2025 - June 3, 2025 ...
EP: 4.Impact of Risk Status on Treatment Pathways in Newly Diagnosed Multiple Myeloma EP: 5.Treatment Options for Transplant-Ineligible Newly Diagnosed Multiple Myeloma EP: 6.Determining Frailty in Patients With Newly Diagnosed Multiple Myeloma EP: 7.Treatment Duration in Patients With Newly Diagno...
EP: 12.Bispecifics in Multiple Myeloma: Dosing and Transition of Care EP: 13.Combination Strategies With Bispecifics in Multiple Myeloma EP: 14.Bispecifics in Multiple Myeloma: Adverse Event Management EP: 15.CAR T-Cell Therapy in Multiple Myeloma: Updates from ASCO 2023 and Beyond Now Viewin...
Data From 2023 ASH Annual Meeting Provide Positive Updates in Multiple MyelomaDOHERTY, KYLEOncologyLive
Multiple myeloma cases are increasing in Asia, with the region currently contributing to more than 35% of the projected global incidence, with Chin
Joshua Richter, MD, led an enthusiastic panel with his colleagues in the multiple myeloma space following the 2023 ASH Annual Meeting and Exposition.
The natural history of multiple myeloma (MM) was revolutionized by the introduction of haematopoietic stem cell transplantation to the treatment armamentarium of this disease. Defined subgroups of MM patients (such as the elderly or dialysis-dependent) have required an individualized approach in order ...
T-cell redirecting therapy (TCRT), specifically chimeric antigen receptor T-cell therapy (CAR T-cells) and bispecific T-cell engagers (TCEs) represent a remarkable advance in the treatment of multiple myeloma (MM). There are several products available around the world and several more in develo...
The multiple myeloma condition center is a comprehensive resource for clinical news and expert insights on multiple myeloma. Read more at OncLive.